Predictive value of procalcitonin in children with suspected sepsis

被引:7
作者
Bustos B, Raul [1 ]
Padilla P, Oslando [2 ]
机构
[1] Hosp Guillermo Grant Benavente, Unidad Cuidado Intens Pediat, Concepcion, Chile
[2] Pontificia Univ Catolica, Escuela Med, Div Salud Publ, Santiago, Chile
来源
REVISTA CHILENA DE PEDIATRIA-CHILE | 2015年 / 86卷 / 05期
关键词
Sepsis; Biomarkers; Procalcitonin; C Reactive Protein;
D O I
10.1016/j.rchipe.2015.07.006
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Introduction: The use of biomarkers could be a tool for diagnosis, prognosis and stratifying children with sepsis. Our main goal was to analyze the value of procalcitonin (PCT), C reactive protein (CRP) and lactate in predicting mortality, septic shock and the stratification in children with suspected sepsis Patients and method: Prospective study in 81 patients. Plasma levels of PCT, CRP and lactate were measured at admission in the pediatric intensive care unit. Patients were categorized into systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock. Results: Concentrations of PCT (ng/mL) increased significantly according to the severity of sepsis: 0.36 (0-1.2) for systemic inflammatory response syndrome; 1.96 (0.4-3.5) for sepsis; 7.5 (3.9-11.1) for severe sepsis; and 58.9 (35.1-82.7) for septic shock (P < .001). Compared to CRP and lactate, the area under the ROC curve revealed a good discriminative power of PCT to predict septic shock and mortality, 0.91 (95% CI: 0.83-0.97) and 0.80 (95% CI: 0.69-0.88), respectively. Conclusions: In contrast to CRP and lactate, the determination of PCT in pediatric intensive care unit admission is a good predictor of mortality and septic shock and can stratify patients according to severity of sepsis. (C) 2015 Sociedad Chilena de Pediatria. Published by Elsevier Espana, S.L.U.
引用
收藏
页码:331 / 336
页数:6
相关论文
共 23 条
[1]  
Casado-Flores Juan, 2003, Pediatr Crit Care Med, V4, P190, DOI 10.1097/01.PCC.0000059420.15811.2D
[2]   Diagnostic and prognostic value of procalcitonin in patients with septic shock [J].
Clec'h, C ;
Ferriere, F ;
Karoubi, P ;
Fosse, JP ;
Cupa, M ;
Hoang, P ;
Cohen, Y .
CRITICAL CARE MEDICINE, 2004, 32 (05) :1166-1169
[3]  
DELLINGER RP, 2013, INTENS CARE MED, V39, P165, DOI DOI 10.1007/s00134-012-2769-8
[4]   Combination Biomarkers to Diagnose Sepsis in the Critically Ill Patient [J].
Gibot, Sebastien ;
Bene, Marie C. ;
Noel, Robin ;
Massin, Frederic ;
Guy, Julien ;
Cravoisy, Aurelie ;
Barraud, Damien ;
Bittencourt, Marcelo De Carvalho ;
Quenot, Jean-Pierre ;
Bollaert, Pierre-Edouard ;
Faure, Gilbert ;
Charles, Pierre-Emmanuel .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 186 (01) :65-71
[5]   ENHANCE: Results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis [J].
Goldstein, Brahm ;
Nadel, Simon ;
Peters, Mark ;
Barton, Roger ;
Machado, Flavia ;
Levy, Howard ;
Haney, Douglas J. ;
Utterback, Barbara ;
Williams, Mark D. ;
Giroir, Brett P. .
PEDIATRIC CRITICAL CARE MEDICINE, 2006, 7 (03) :200-211
[6]   Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis [J].
Harbarth, S ;
Holeckova, K ;
Froidevaux, C ;
Pittet, D ;
Ricou, B ;
Grau, GE ;
Vadas, L ;
Pugin, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (03) :396-402
[7]  
Hatherill M, 1999, ARCH DIS CHILD, V81, P417, DOI 10.1136/adc.81.5.417
[8]   Procalcitonin increase in early identification of critically ill patients at high risk of mortality [J].
Jensen, Jens Ulrik ;
Heslet, Lars ;
Jensen, Tom Hartvig ;
Espersen, Kurt ;
Steffensen, Peter ;
Tvede, Michael .
CRITICAL CARE MEDICINE, 2006, 34 (10) :2596-2602
[9]   Biomarker discovery and development in pediatric critical care medicine [J].
Kaplan, Jennifer M. ;
Wong, Hector R. .
PEDIATRIC CRITICAL CARE MEDICINE, 2011, 12 (02) :165-173
[10]   Biomarkers of sepsis [J].
Marshall, John C. ;
Reinhart, Konrad .
CRITICAL CARE MEDICINE, 2009, 37 (07) :2290-2298